iXMD™ Blood Glucose Monitoring

Umbrella Technologies’ iXMD™ BioSensor system integrates biochemistry and electronics to alert health care professionals, researchers, scientists, first-responders, pharmaceutical manufacturers, and others to the presence and constant monitoring of blood sugar in real-time.

The blood sugar concentration or blood glucose level is the amount of glucose (sugar) present in the blood of a human or animal. Normally, the body maintains a blood glucose level at a reference range between about 3.6 and 5.8 mM. Blood glucose levels are tightly regulated as a part of metabolic homeostasis of the body. Sugar levels that are outside the normal range (3.6 and 5.8 mM) may be an indicator of a medical condition. A persistently high level is referred to as hyperglycemia; low levels are referred to as hypoglycemia. Diabetes mellitus is characterized by persistent hyperglycemia from any of several causes and is the most prominent disease related to failure of blood sugar regulation.
The advantages of XMD™
  • Self-calibrated
  • No glucose level lag
  • Instantaneous
  • Closed-loop system
  • Real-time insulin pump control
Between 2003 and 2008, Umbrella Technologies was involved in the design and development of advanced biological sensors that have demonstrated sensitivity levels of 3*10^-18 g/ml (3 attograms per milliliter) in real-time (less than 20 seconds). The sensor has been tested on bacteria, spores, viruses and proteins. Since 2009, Umbrella Technologies has been actively developing the new generation of iX™ BioSensors for real-time, unbiased, multi-channel, large area bio-sensor technologies. The new design of the iX™ BioSensor line incorporates the latest innovations and discoveries of Umbrella’s unparalleled research team.
Umbrella Technologies is currently seeking strategic partners to help further implement the iX™ sensor technologies.